Moreover, TDF-treated patients exhibited elevated levels of serum interferon (IFN)-λ3 (Murata et al., 2018; Umemura et al., 2022), a factor known to have the potential to directly or indirectly inhibit tumor growth (Stiff and Carson, 2015). The gene discussed is IFNL3; the disease is neoplasm.